Pure Global
Disease / condition

Influenza clinical trials

Free access to 1,074 studies·10+ countries·Updated daily50 recruiting
1,074
Total trials
10+
Countries
10+
Sponsors
50
Recruiting
By phase
N/A228
Phase 3224
Phase 2185
Phase 4184
Phase 1146
By status
Completed837
Unknown73
Recruiting50
Not yet recruit...45
Terminated29
Top countries
United States of America341
China73
United Kingdom49
Japan46
Canada38
Top sponsors
GlaxoSmithKline139
National Institute...108
Sanofi Pasteur, a ...58
MedImmune LLC27
Novartis Vaccines27
Recent trials
Latest clinical trials for Influenza
2018-003701-26
A study to see the effect of Trivalent and Quadrivalent formulations of FluMist on the immune response of children 24 to < 48 months of age
MedImmune LLC
2021-001026-22
This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with Influenza
Shionogi & Co., Ltd.
2014-004248-36
The administration of adjuvanted Trivalent Influenza Vaccine (aTIV) has come to result in a more immunogenic and effective response compared with conventional influenza vaccines in elderly and adults.
Novartis Pharma Services AG
2016-003003-54
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
F. Hoffmann-La Roche AG
2016-001008-49
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain
F. Hoffmann-La Roche AG
2016-003004-31
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
F. Hoffmann-La Roche AG
2014-004543-12
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months.
Novartis Vaccines and Diagnost...
2014-004757-14
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
Novartis Vaccines and Diagnost...
2020-000696-20
This study will evaluate the effectiveness of a single dose of Baloxavir Marboxil to prevent the spread of influenza virus infection
Shionogi & Co., Ltd.
PHRR221013-004996·Phase 3Suspended
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
Seqirus UK LimitedBangladesh;Bulgaria;Colombia;Estonia;Lithuania;Philippines;Poland;Romania;Serbia;Turkey
PHRR221122-005169·Phase 3Ongoing
A Phase III, Randomized, Observer-blind, Multicenter Study to Evaluate the Efficacy, Immunogenicity and Safety of Seqirus’ Cell-Based Quadrivalent SubunitInfluenza Virus Vaccine (QIVc) Compared to a Non-Influenza Vaccine when Administrated in Healthy Subjects aged 6 Months through 47 Months
Seqirus UK LimitedBangladesh Philippines South Africa
2014-004515-37
A phase II study, performed over a period of approximately 20 months,
Novartis Vaccines and Diagnost...
NCT06342349·Phase 1Not yet recr...
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
Shanghai Institute Of Biologic...
NCT06274359Not yet recr...
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities
Denver Health and Hospital Aut...United States of America
NCT06207058Not yet recr...
Evaluation of a Screen and Treat Protocol for Influenza
Tricore, Inc
NCT06125717·Phase 1Completed
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
Vaxess TechnologiesCanada
NCT06141655·Phase 4Recruiting
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Federico Martinón TorresSpain
NCT06103994Recruiting
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
The Archer-Daniels-Midland Com...Greece
NCT06094010·Phase 3Recruiting
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza
Hoffmann-La RocheUnited States of America
NCT06054269·Phase 3Recruitment ...
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Centers for Disease Control an...Peru
View all 1,074 trials →
About this record

Access comprehensive clinical trial information for Influenza through Pure Global AI's free database. This collection includes 1,074 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 50 trials are actively recruiting participants.

Research for Influenza is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include GlaxoSmithKline and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,074 clinical trials studying Influenza, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi Pasteur, a Sanofi Company, among others.